Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Cineverse Corp.CIDM · Entity 7143 | Director | November 26, 2019 | December 05, 2019 |
| SELECTIS HEALTH, INC.GBCS · Entity 9641 | Director · President and CFO | April 18, 2019 | November 14, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Cineverse Corp.
Report date November 26, 2019 · Filed December 05, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 204,431 |
Reported balance
After 2019-11-26 transaction · row 1
1 source rowRow 1 · 2019-11-26 · Other · Acquired 29,095 · Balance 204,431 F4: On November 26, 2019, the Fund distributed to its partners an aggregate of 145,000 shares of Class A Common Stock, 29,095 of which were distributed to the Reporting Person. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 0 |
Reported balance
After 2019-11-26 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2019-11-26 · Other · Disposed 145,000 · Balance 0 F4: On November 26, 2019, the Fund distributed to its partners an aggregate of 145,000 shares of Class A Common Stock, 29,095 of which were distributed to the Reporting Person. F1: Owned by Sabra Investments, LP (the "Fund"). F3: The General Partner, as the general partner of the Fund, may be deemed to beneficially owned the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the General Partner, the Reporting Person may be deemed to beneficially own the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly disclaims such beneficial ownership except to the extent of any pecuniary interest therein. |
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnotes | 7,400 |
Reported balance
Holding disclosure · report date 2019-11-26 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 7,400 F2: Owned by Sabra Capital Partners, LLC (the "General Partner"). F3: The General Partner, as the general partner of the Fund, may be deemed to beneficially owned the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the General Partner, the Reporting Person may be deemed to beneficially own the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly disclaims such beneficial ownership except to the extent of any pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Owned by Sabra Investments, LP (the "Fund").
F2: Owned by Sabra Capital Partners, LLC (the "General Partner").
F3: The General Partner, as the general partner of the Fund, may be deemed to beneficially owned the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the General Partner, the Reporting Person may be deemed to beneficially own the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly disclaims such beneficial ownership except to the extent of any pecuniary interest therein.
F4: On November 26, 2019, the Fund distributed to its partners an aggregate of 145,000 shares of Class A Common Stock, 29,095 of which were distributed to the Reporting Person.
SELECTIS HEALTH, INC.
Report date April 18, 2019 · Filed November 14, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 1,640,727 |
Reported balance
After 2019-04-18 transaction · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · 2019-04-18 · Grant · Acquired 272,727 · Balance 1,640,727 F1: Shares issued pursuant to a performance bonus valued at $90,000 |
| Common StockSEC Table I · non-derivative | Direct | 1,752,575 |
Reported balance
After 2019-11-07 transaction · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · 2019-11-07 · Grant · Acquired 111,848 · Balance 1,752,575 F2: Shares distributed to Reporting Person upon a pro-rata distribution of shares by Sabra Investments, LP |
| Common StockSEC Table I · non-derivative | Direct | 1,368,000 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 1,368,000 |
| Common StockSEC Table I · non-derivative | IndirectSabra Investments, LP, of which Reporting Person is a control person. | 0 |
Reported balance
After 2019-11-07 transaction · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · 2019-11-07 · Disposition to issuer · Disposed 555,000 · Balance 0 F3: Shares were distributed pro-rata to limited partners upon liquidation of the LP. The Shares are valued at $0.75 per share. |
| Common StockSEC Table I · non-derivative | IndirectSabra Investments, LP, of which Reporting Person is a control person. | 555,000 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 555,000 |
| WarrantsSEC Table II · derivative / convertible security · Conversion / exercise price $0.50 · Expires 2021-12-13 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 50,000 |
| OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $0.36 · Expires 2023-04-01 | Direct | 600,000 |
Reported balance
Holding disclosure · report date 2019-04-18 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 600,000 F4: 150,000 options are exercisable as of 4/1/18; 150,000 options are exercisable as of 4/1/19; 150,000 options are exercisable as of 10/1/19 and 150,000 options are exercisable as of 4/1/20 |
Filing footnotes · ownership attribution and instrument terms
F1: Shares issued pursuant to a performance bonus valued at $90,000
F2: Shares distributed to Reporting Person upon a pro-rata distribution of shares by Sabra Investments, LP
F3: Shares were distributed pro-rata to limited partners upon liquidation of the LP. The Shares are valued at $0.75 per share.
F4: 150,000 options are exercisable as of 4/1/18; 150,000 options are exercisable as of 4/1/19; 150,000 options are exercisable as of 10/1/19 and 150,000 options are exercisable as of 4/1/20
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 26, 2019 Filed Dec 5, 2019 21:10 UTC | Cineverse Corp. CIDM · Entity 7143 | OtherClass A Common Stock | 145,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000932440-19-000068 · edgar.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnotes Disclosed balance after: 0 F4 · kind: On November 26, 2019, the Fund distributed to its partners an aggregate of 145,000 shares of Class A Common Stock, 29,095 of which were distributed to the Reporting Person. F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owned the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the General Partner, the Reporting Person may be deemed to beneficially own the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly disclaims such beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| November 26, 2019 Filed Dec 5, 2019 21:10 UTC | Cineverse Corp. CIDM · Entity 7143 | OtherClass A Common Stock | 29,095 | $0.00 | $0.00 |
DisclosureSEC source: 0000932440-19-000068 · edgar.xml · nonDerivative · entry 1 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 204,431 F4 · kind: On November 26, 2019, the Fund distributed to its partners an aggregate of 145,000 shares of Class A Common Stock, 29,095 of which were distributed to the Reporting Person. Read SEC document |
| November 07, 2019 Filed Nov 14, 2019 22:27 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | Disposition to issuerCommon Stock | 555,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-017598 · ownership.xml · nonDerivative · entry 5 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Indirect · Sabra Investments, LP, of which Reporting Person is a control person. Disclosed balance after: 0 F3 · price: Shares were distributed pro-rata to limited partners upon liquidation of the LP. The Shares are valued at $0.75 per share. Read SEC document |
| November 07, 2019 Filed Nov 14, 2019 22:27 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 111,848 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-017598 · ownership.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,752,575 F2 · price: Shares distributed to Reporting Person upon a pro-rata distribution of shares by Sabra Investments, LP Read SEC document |
| April 18, 2019 Filed Nov 14, 2019 22:27 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 272,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-19-017598 · ownership.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,640,727 F1 · price: Shares issued pursuant to a performance bonus valued at $90,000 Read SEC document |
| December 12, 2018 Filed Dec 14, 2018 21:25 UTC | Cineverse Corp. CIDM · Entity 7143 | GrantClass A Common Stock | 43,103 | $0.00 | $0.00 |
DisclosureSEC source: 0000932440-18-000107 · edgar.xml · nonDerivative · entry 1 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,336 F4 · shares: Constitutes stock portion of annual retainer for the year of board service by the Reporting Person commencing October 1, 2018. Such shares vest in quarterly amounts on December 31, 2018, March 31, 2019, June 30, 2019 and September 30, 2019, so long as the Reporting Person is a director on each such date. Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:26 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantOptions · Derivative | 150,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-18-006393 · form4.xml · derivative · entry 8 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-04-01 Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:26 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantOptions · Derivative | 150,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-18-006393 · form4.xml · derivative · entry 7 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-04-01 Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:26 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantOptions · Derivative | 150,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-18-006393 · form4.xml · derivative · entry 6 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-04-01 Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:26 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantOptions · Derivative | 150,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-18-006393 · form4.xml · derivative · entry 5 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2023-04-01 Read SEC document |
| May 04, 2018 Filed May 8, 2018 17:26 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 150,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-006393 · form4.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,368,000 F1 · price: Restricted Stock Award subject to vesting 50% after one year; 50% after two years. Read SEC document |
| January 23, 2018 Filed Jan 23, 2018 20:52 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 93,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-18-000914 · form4.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · President and CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,218,832 F1 · price: Shares acquired in exchange for services as a Director valued at $0.32 per share. Read SEC document |
| November 27, 2017 Filed Jan 30, 2018 21:50 UTC | Cineverse Corp. CIDM · Entity 7143 | GrantClass A Common Stock | 34,483 | $0.00 | $0.00 |
DisclosureSEC source: 0000932440-18-000010 · edgar.xml · nonDerivative · entry 1 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,233 F4 · shares: Constitutes stock portion of annual retainer for the year of board service by the Reporting Person commencing October 1, 2017. Such shares vest in quarterly amounts on December 31, 2017, March 31, 2018, June 30, 2018 and September 30, 2018, so long as the Reporting Person is a director on each such date. Read SEC document |
| August 07, 2017 Filed Aug 7, 2017 22:05 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 168,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-008603 · form4.xml · nonDerivative · entry 4 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,125,082 F2 · price: Shares acquired as retainer for period July 1, 2017 through December 31, 2017 valued at $0.4211 per share. Read SEC document |
| August 07, 2017 Filed Aug 7, 2017 22:05 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 84,444 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-008603 · form4.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 956,193 F1 · price: Shares acquired in exchange for services as CFO performed during 2nd Qtr. 2017 valued at $0.4211 per share. Read SEC document |
| April 21, 2017 Filed Apr 21, 2017 10:15 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 29,269 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-004262 · form4.xml · nonDerivative · entry 4 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 871,749 F2 · price: Shares awarded for extraordinary services relative to property acquisition valued at $0.44 per share. Read SEC document |
| April 21, 2017 Filed Apr 21, 2017 10:15 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 86,364 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-004262 · form4.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 842,480 F1 · price: Shares acquired in exchange for services as CFO performed during 1st Qtr. 2017 valued at $0.44 per share. Read SEC document |
| March 15, 2017 Filed Mar 15, 2017 22:18 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 87,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-002475 · form4.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 756,116 F1 · price: Shares acquired in exchange for services as CFO performed during 4th Qtr. 2016 valued at $0.41 per share. Read SEC document |
| March 06, 2017 Filed Mar 6, 2017 22:44 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 2,700 | $1.46 | $3,942.00 |
DisclosureSEC source: 0000932440-17-000016 · edgar.xml · nonDerivative · entry 5 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 145,000 F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| March 06, 2017 Filed Mar 29, 2017 20:55 UTC | Cineverse Corp. CIDM · Entity 7143 | GrantClass A Common Stock | 24,631 | $0.00 | $0.00 |
DisclosureSEC source: 0000932440-17-000028 · edgar.xml · nonDerivative · entry 1 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,750 F4 · shares: Constitutes stock portion of annual retainer for the year of board service by the Reporting Person commencing October 1, 2016. Such shares vest in quarterly amounts on December 31, 2016, March 31, 2017, June 30, 2017 and September 30, 2017, so long as the Reporting Person is a director on each such date. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:44 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 5,300 | $1.47 | $7,791.00 |
DisclosureSEC source: 0000932440-17-000016 · edgar.xml · nonDerivative · entry 4 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 142,300 F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| March 03, 2017 Filed Mar 6, 2017 22:44 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 2,000 | $1.46 | $2,920.00 |
DisclosureSEC source: 0000932440-17-000016 · edgar.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 137,000 F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:44 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 5,000 | $1.55 | $7,750.00 |
DisclosureSEC source: 0000932440-17-000016 · edgar.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 135,000 F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| March 02, 2017 Filed Mar 6, 2017 22:44 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 5,000 | $1.55 | $7,750.00 |
DisclosureSEC source: 0000932440-17-000016 · edgar.xml · nonDerivative · entry 1 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,119 Read SEC document |
| January 13, 2017 Filed Jan 14, 2017 00:14 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantWarrants · Derivative | 50,000 | $0.75 Strike: $0.75 | $37,500.00 |
DisclosureSEC source: 0001493152-17-000489 · form4.xml · derivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2018-01-13 Read SEC document |
| January 12, 2017 Filed Jan 19, 2017 18:10 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 52,632 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-17-000630 · form4.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 669,116 F1 · price: Shares acquired in exchange for services as a Director valued at $0.57 per share. Read SEC document |
| December 28, 2016 Filed Dec 29, 2016 21:51 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 7,156 | $1.40 | $10,018.40 |
DisclosureSEC source: 0000932440-16-000537 · edgar.xml · nonDerivative · entry 3 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 130,000 F5 · price: Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $1.40 to $1.41 The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction. F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| December 27, 2016 Filed Dec 29, 2016 21:51 UTC | Cineverse Corp. CIDM · Entity 7143 | PurchaseClass A Common Stock | 15,844 | $1.40 | $22,181.60 |
DisclosureSEC source: 0000932440-16-000537 · edgar.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 122,844 F4 · price: Constitutes the weighted average purchase price for multiple transactions reported on this line having prices per share ranging from $1.40 to $1.42. The Reporting Persons will provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding each separate transaction. F1 · ownership.nature: Owned by Sabra Investments, LP (the "Fund"). F3 · ownership.nature: The General Partner, as the general partner of the Fund, may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund in this statement. As the principal of the Fund and the Genera Partner, the Reporting Person may be deemed to beneficially owne the shares of Class A Common Stock disclosed as directly owned by the Fund and the General Partner in this statement. Each of the General Partner and the Reporting Person expressly discloaims siuch beneficial ownership except to the extent of any pecuniary interest therein. Read SEC document |
| December 23, 2016 Filed Dec 23, 2016 19:51 UTC | SELECTIS HEALTH, INC. GBCS · Entity 9641 | GrantCommon Stock | 95,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-16-016184 · form4.xml · nonDerivative · entry 2 Rhine Zvi Michael · CIK 0001644923 · Director · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 616,484 F1 · price: Shares were acquired in exchange of services as Chief Financial Officer valued at $0.40 per share. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.